Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH

Clinical trial NCT06297434 · COMPLETED

Trial details

NCT number: NCT06297434
Sponsor: J2H Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis

Start date: 2023-02-15
Primary completion: 2025-06-26
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.